Oliver Findling
Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort.
Greselin M, Lu P, Melie-Garcia L, Ocampo-Pineda M, Galbusera R, Cagol A, Weigel M, de Oliveira Siebenborn N, Ruberte E, Benkert P, Müller S, Finkener S, Vehoff J, Giulio D, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb J, Diepers M, Wagner F, Vargas M, Du Pasquier R, Lalive P, Pravatà E, Weber J, Gobbi C, Leppert D, Kim O, Cattin P, Hoepner R, Roth P, Kappos L, Kuhle J, Granziera C. Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort. Bioengineering (Basel) 2024; 11
Aug 22, 2024Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort.
Aug 22, 2024Bioengineering (Basel) 2024; 11
Greselin Martina, Lu Po-Jui, Melie-Garcia Lester, Ocampo-Pineda Mario, Galbusera Riccardo, Cagol Alessandro, Weigel Matthias, de Oliveira Siebenborn Nina, Ruberte Esther, Benkert Pascal, Müller Stefanie, Finkener Sebastian, Vehoff Jochen, Giulio Disanto, Findling Oliver, Chan Andrew T, Salmen Anke, Pot Caroline, Bridel Claire, Zecca Chiara, Derfuss Tobias, Lieb Johanna Maria, Diepers Michael, Wagner Franca, Vargas Maria Isabel, Du Pasquier Renaud A, Lalive Patrice H, Pravatà Emanuele, Weber Johannes, Gobbi Claudio, Leppert David, Kim Olaf Chan-Hi, Cattin Philippe C, Hoepner Robert, Roth Patrick, Kappos Ludwig, Kuhle Jens, Granziera Cristina
Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Cagol A, Benkert P, Melie-Garcia L, Schaedelin S, Leber S, Tsagkas C, Barakovic M, Galbusera R, Lu P, Weigel M, Ruberte E, Radue E, Yaldizli O, Oechtering J, Lorscheider J, D'Souza M, Fischer-Barnicol B, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb J, Remonda L, Wagner F, Vargas M, Du Pasquier R, Lalive P, Pravatà E, Weber J, Cattin P, Absinta M, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C. Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology 2023; 102:e207768.
Dec 13, 2023Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Dec 13, 2023Neurology 2023; 102:e207768
Cagol Alessandro, Benkert Pascal, Melie-Garcia Lester, Schaedelin Sabine A, Leber Selina, Tsagkas Charidimos, Barakovic Muhamed, Galbusera Riccardo, Lu Po-Jui, Weigel Matthias, Ruberte Esther, Radue Ernst-Wilhelm, Yaldizli Ozgür, Oechtering Johanna, Lorscheider Johannes, D'Souza Marcus, Fischer-Barnicol Bettina, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Chan Andrew T, Salmen Anke, Pot Caroline, Bridel Claire, Zecca Chiara, Derfuss Tobias, Lieb Johanna Maria, Remonda Luca, Wagner Franca, Vargas Maria Isabel, Du Pasquier Renaud A, Lalive Patrice H, Pravatà Emanuele, Weber Johannes, Cattin Philippe C, Absinta Martina, Gobbi Claudio, Leppert David, Kappos Ludwig, Kuhle Jens, Granziera Cristina
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
Todea A, Melie-Garcia L, Barakovic M, Cagol A, Rahmanzadeh R, Galbusera R, Lu P, Weigel M, Ruberte E, Radue E, Schaedelin S, Benkert P, Oezguer Y, Sinnecker T, Müller S, Achtnichts L, Vehoff J, Disanto G, Findling O, Chan A, Salmen A, Pot C, Lalive P, Bridel C, Zecca C, Derfuss T, Remonda L, Wagner F, Vargas M, Du Pasquier R, Pravatà E, Weber J, Gobbi C, Leppert D, Wuerfel J, Kober T, Marechal B, Corredor-Jerez R, Psychogios M, Lieb J, Kappos L, Cuadra M, Kuhle J, Granziera C. A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. J Magn Reson Imaging 2023
Jan 28, 2023A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
Jan 28, 2023J Magn Reson Imaging 2023
Todea Alexandra Ramona, Melie-Garcia Lester, Barakovic Muhamed, Cagol Alessandro, Rahmanzadeh Reza, Galbusera Riccardo, Lu Po-Jui, Weigel Matthias, Ruberte Esther, Radue Ernst-Wilhelm, Schaedelin Sabine, Benkert Pascal, Oezguer Yaldizli, Sinnecker Tim, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Disanto Giulio, Findling Oliver, Chan Andrew, Salmen Anke, Pot Caroline, Lalive Patrice, Bridel Claire, Zecca Chiara, Derfuss Tobias, Remonda Luca, Wagner Franca, Vargas Maria I, Du Pasquier Renaud, Pravatà Emanuele, Weber Johannes, Gobbi Claudio, Leppert David, Wuerfel Jens, Kober Tobias, Marechal Benedicte, Corredor-Jerez Ricardo, Psychogios Marios, Lieb Johanna, Kappos Ludwig, Cuadra Meritxell Bach, Kuhle Jens, Granziera Cristina
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).
Achtnichts L, Zecca C, Findling O, Kamm C, Müller S, Kuhle J, Lutterotti A, Gobbi C, Viviani C, Villiger-Borter E, Nedeltchev K. Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS). BMJ Neurol Open 2023; 5:e000304.
Jan 26, 2023Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).
Jan 26, 2023BMJ Neurol Open 2023; 5:e000304
Achtnichts Lutz, Zecca Chiara, Findling Oliver, Kamm Christian Philipp, Müller Stefanie, Kuhle Jens, Lutterotti Andreas, Gobbi Claudio, Viviani Camille, Villiger-Borter Emanuela, Nedeltchev Krassen
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
Cagol A, Schaedelin S, Barakovic M, Benkert P, Todea R, Rahmanzadeh R, Galbusera R, Lu P, Weigel M, Melie-Garcia L, Ruberte E, Siebenborn N, Battaglini M, Radue E, Yaldizli O, Oechtering J, Sinnecker T, Lorscheider J, Fischer-Barnicol B, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb J, Remonda L, Wagner F, Vargas M, Du Pasquier R, Lalive P, Pravatà E, Weber J, Cattin P, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C. Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis. JAMA Neurol 2022; 79:682-692.
Jul 1, 2022Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
Jul 1, 2022JAMA Neurol 2022; 79:682-692
Cagol Alessandro, Schaedelin Sabine A, Barakovic Muhamed, Benkert Pascal, Todea Ramona-Alexandra, Rahmanzadeh Reza, Galbusera Riccardo, Lu Po-Jui, Weigel Matthias, Melie-Garcia Lester, Ruberte Esther, Siebenborn Nina, Battaglini Marco, Radue Ernst-Wilhelm, Yaldizli Ozgür, Oechtering Johanna, Sinnecker Tim, Lorscheider Johannes, Fischer-Barnicol Bettina, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Chan Andrew T, Salmen Anke, Pot Caroline, Bridel Claire, Zecca Chiara, Derfuss Tobias, Lieb Johanna Maria, Remonda Luca, Wagner Franca, Vargas Maria I, Du Pasquier Renaud A, Lalive Patrice H, Pravatà Emanuele, Weber Johannes, Cattin Philippe C, Gobbi Claudio, Leppert David, Kappos Ludwig, Kuhle Jens, Granziera Cristina
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Oechtering J, Naegelin Y, Maceski A, Meier S, Berger K, Wiendl H, Lincke T, Lieb J, Yaldizli O, Sinnecker T, Derfuss T, Regeniter A, Zecca C, Gobbi C, Kappos L, Granziera C, Leppert D, Kuhle J, Conen D, Aeschbacher S, Subramaniam S, Schaedelin S, Benkert P, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Fischer-Barnicol B, Orleth A, Chan A, Pot C, Barakovic M, Rahmanzadeh R, Galbusera R, Heijnen I, Lalive P, Wuerfel J, Swiss Multiple Sclerosis Cohort Study. Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis. Ann Neurol 2021; 90:477-489.
Jun 22, 2021Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Jun 22, 2021Ann Neurol 2021; 90:477-489
Oechtering Johanna, Naegelin Yvonne, Maceski Aleksandra, Meier Stephanie, Berger Klaus, Wiendl Heinz, Lincke Therese, Lieb Johanna, Yaldizli Ozgür, Sinnecker Tim, Derfuss Tobias, Regeniter Axel, Zecca Chiara, Gobbi Claudio, Kappos Ludwig, Granziera Cristina, Leppert David, Kuhle Jens, Conen David, Aeschbacher Stefanie, Subramaniam Suvitha, Schaedelin Sabine, Benkert Pascal, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Fischer-Barnicol Bettina, Orleth Annette, Chan Andrew, Pot Caroline, Barakovic Muhamed, Rahmanzadeh Reza, Galbusera Riccardo, Heijnen Ingmar, Lalive Patrice H, Wuerfel Jens, Swiss Multiple Sclerosis Cohort Study
A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score.
De Marchis G, Dankowski T, König I, Fladt J, Fluri F, Gensicke H, Foerch C, Findling O, Kurmann R, Fischer U, Luft A, Buhl D, Engelter S, Lyrer P, Christ-Crain M, Arnold M, Katan M. A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score. Neurology 2019; 92:e1517-e1525.
Mar 1, 2019A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score.
Mar 1, 2019Neurology 2019; 92:e1517-e1525
De Marchis Gian Marco, Dankowski Theresa, König Inke R, Fladt Joachim, Fluri Felix, Gensicke Henrik, Foerch Christian, Findling Oliver, Kurmann Rebekka, Fischer Urs, Luft Andreas R, Buhl Daniela, Engelter Stefan T, Lyrer Philippe A, Christ-Crain Mirjam, Arnold Marcel, Katan Mira
Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary.
Achtnichts L, Salmen A, Chan A, Czaplinski A, Derfuss T, Du Pasquier R, Findling O, Gobbi C, Zecca C, Müller S, Kamm C, Kuhle J, Lalive P, Martin R, Pot C, Papadopoulou A. Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and Translational Neuroscience 2019
Mar 1, 2019Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary.
Mar 1, 2019Clinical and Translational Neuroscience 2019
Achtnichts Lutz, Salmen Anke, Chan Andrew, Czaplinski Adam, Derfuss Tobias, Du Pasquier R, Findling Oliver, Gobbi Claudio, Zecca Chiara, Müller Stefanie, Kamm CP, Kuhle Jens, Lalive Patrice H, Martin Roland, Pot Caroline, Papadopoulou Athina
36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry
Scheidegger O, Leupold D, Sauter R, Findling O, Rösler K, Hundsberger T. 36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry. J Neurol 2018
Sep 19, 201836-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry
Sep 19, 2018J Neurol 2018
Scheidegger Olivier, Leupold Daniela, Sauter Rafael, Findling Oliver, Rösler Kai Michael, Hundsberger Thomas
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Giulio D, Kamm C, Mattle H, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive P, Yaldizli O, Gobbi C, Kappos L, Kuhle J, Louvion J, Derfuss T, Stippich C, Benkert P, Lorscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue E, Sprenger T, SMSC Scientific Board. The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PloS one 2016; 11:e0152347.
Mar 31, 2016The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Mar 31, 2016PloS one 2016; 11:e0152347
Giulio Disanto, Kamm Christian P, Mattle Heinrich P, Lotter Christoph, Du Pasquier Renaud, Schluep Myriam, Pot Caroline, Lalive Patrice H, Yaldizli Ozgür, Gobbi Claudio, Kappos Ludwig, Kuhle Jens, Louvion Jean-François, Derfuss Tobias, Stippich Christoph, Benkert Pascal, Lorscheider Johannes, Müller Stefanie, Vehoff Jochen, Zecca Chiara, Ramseier Simon, Achtnichts Lutz, Findling Oliver, Nedeltchev Krassen, Radue Ernst-Wilhelm, Sprenger Till, SMSC Scientific Board
Long-Term Interruption of Enzyme Replacement Therapy with rhGAA in Pompe Disease Leads to Irreversible Clinical Decline
Hundsberger T, Rösler K, Findling O. Long-Term Interruption of Enzyme Replacement Therapy with rhGAA in Pompe Disease Leads to Irreversible Clinical Decline. J Neuromuscul Dis 2015; 2:S20.
Jan 1, 2015Long-Term Interruption of Enzyme Replacement Therapy with rhGAA in Pompe Disease Leads to Irreversible Clinical Decline
Jan 1, 2015J Neuromuscul Dis 2015; 2:S20
Hundsberger Thomas, Rösler Kai M, Findling Oliver
Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis
Hundsberger T, Rösler K, Findling O. Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis. J Neurol 2014; 261:1684-1690.
Jun 13, 2014Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis
Jun 13, 2014J Neurol 2014; 261:1684-1690
Hundsberger Thomas, Rösler Kai M, Findling Oliver
Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
De Marchis G, Katan M, Weck A, Fluri F, Foerch C, Findling O, Schuetz P, Buhl D, El-Koussy M, Gensicke H, Seiler M, Morgenthaler N, Mattle H, Müller-Stich B, Christ-Crain M, Arnold M. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study. Neurology 2013; 80:1278-86.
Mar 6, 2013Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
Mar 6, 2013Neurology 2013; 80:1278-86
De Marchis Gian Marco, Katan Mira, Weck Anja, Fluri Felix, Foerch Christian, Findling Oliver, Schuetz Philipp, Buhl Daniela, El-Koussy Marwan, Gensicke Henrik, Seiler Marlen, Morgenthaler Nils G, Mattle Heinrich Paul, Müller-Stich Beat P, Christ-Crain Mirjam, Arnold Marcel
Plaque characteristics of asymptomatic carotid stenosis and risk of stroke.
Mono M, Karameshev A, Slotboom J, Remonda L, Galimanis A, Jung S, Findling O, De Marchis G, Luedi R, Kiefer C, Stuker C, Mattle H, Schroth G, Arnold M, Nedeltchev K, El-Koussy M. Plaque characteristics of asymptomatic carotid stenosis and risk of stroke. Cerebrovasc Dis 2012; 34:343-50.
Nov 14, 2012Plaque characteristics of asymptomatic carotid stenosis and risk of stroke.
Nov 14, 2012Cerebrovasc Dis 2012; 34:343-50
Mono Marie-Luise, Karameshev Alexander, Slotboom Johannes, Remonda Luca, Galimanis Aekaterini, Jung Simon, Findling Oliver, De Marchis Gian Marco, Luedi Rudolf, Kiefer Claus, Stuker Carole, Mattle Heinrich Paul, Schroth Gerhard, Arnold Marcel, Nedeltchev Krassen, El-Koussy Marwan
Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial
Kamm C, Naegelin Y, Kappos L, Tettenborn B, Slotboom J, Müller F, Goebels N, Müller M, Donati F, Schött D, Schwegler G, Burren Y, von Bredow F, Findling O, Humpert S, El-Koussy M, Mattle H. Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial. J Neurol 2012; 259:2401-13.
May 9, 2012Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial
May 9, 2012J Neurol 2012; 259:2401-13
Kamm Christian Philipp, Naegelin Yvonne, Kappos Ludwig, Tettenborn Barbara, Slotboom Johannes, Müller Felix, Goebels Norbert, Müller Martin, Donati Filippo, Schött Dagmar, Schwegler Guido, Burren Yuliya, von Bredow Ferdinand, Findling Oliver, Humpert Sebastian, El-Koussy Marwan, Mattle Heinrich Paul
Endovascular therapy of 623 patients with anterior circulation stroke.
Galimanis A, Jung S, Mono M, Fischer U, Findling O, Weck A, Meier N, De Marchis G, Brekenfeld C, El-Koussy M, Mattle H, Arnold M, Schroth G, Gralla J. Endovascular therapy of 623 patients with anterior circulation stroke. Stroke 2012; 43:1052-7.
Feb 23, 2012Endovascular therapy of 623 patients with anterior circulation stroke.
Feb 23, 2012Stroke 2012; 43:1052-7
Galimanis Aekaterini, Jung Simon, Mono Marie-Luise, Fischer Urs, Findling Oliver, Weck Anja, Meier Niklaus, De Marchis Gian Marco, Brekenfeld Caspar, El-Koussy Marwan, Mattle Heinrich Paul, Arnold Marcel, Schroth Gerhard, Gralla Jan
White matter lesions and intra-arterial thrombolysis.
Jung S, Mono M, Findling O, Fischer U, Galimanis A, Weck A, De Marchis G, Ballinari P, Gralla J, Brekenfeld C, Schroth G, Arnold M, Mattle H, El-Koussy M. White matter lesions and intra-arterial thrombolysis. J Neurol 2012; 259:1331-6.
Jan 17, 2012White matter lesions and intra-arterial thrombolysis.
Jan 17, 2012J Neurol 2012; 259:1331-6
Jung Simon, Mono Marie-Luise, Findling Oliver, Fischer Urs, Galimanis Aekaterini, Weck Anja, De Marchis Gian Marco, Ballinari Pietro, Gralla Jan, Brekenfeld Caspar, Schroth Gerhard, Arnold Marcel, Mattle Heinrich Paul, El-Koussy Marwan
Diffusion-weighted MRI helps predict outcome in basilar artery occlusion patients treated with intra-arterial thrombolysis.
Karameshev A, Arnold M, Schroth G, Kappeler L, Stein P, Gralla J, Brekenfeld C, Findling O, Mono M, De Marchis G, Fischer U, Mattle H, Nedeltchev K, El-Koussy M. Diffusion-weighted MRI helps predict outcome in basilar artery occlusion patients treated with intra-arterial thrombolysis. Cerebrovasc Dis 2011; 32:393-400.
Oct 8, 2011Diffusion-weighted MRI helps predict outcome in basilar artery occlusion patients treated with intra-arterial thrombolysis.
Oct 8, 2011Cerebrovasc Dis 2011; 32:393-400
Karameshev Alexander, Arnold Marcel, Schroth Gerhard, Kappeler Liliane, Stein Paul, Gralla Jan, Brekenfeld Caspar, Findling Oliver, Mono Marie-Luise, De Marchis Gian Marco, Fischer Urs, Mattle Heinrich Paul, Nedeltchev Krassen, El-Koussy Marwan
Outcome after thrombolysis for acute isolated posterior cerebral artery occlusion.
Meier N, Fischer U, Schroth G, Findling O, Brekenfeld C, El-Koussy M, De Marchis G, Mono M, Jung S, Gralla J, Nedeltchev K, Mattle H, Arnold M. Outcome after thrombolysis for acute isolated posterior cerebral artery occlusion. Cerebrovasc Dis 2011; 32:79-88.
Jun 11, 2011Outcome after thrombolysis for acute isolated posterior cerebral artery occlusion.
Jun 11, 2011Cerebrovasc Dis 2011; 32:79-88
Meier Niklaus, Fischer Urs, Schroth Gerhard, Findling Oliver, Brekenfeld Caspar, El-Koussy Marwan, De Marchis Gian Marco, Mono Marie-Luise, Jung Simon, Gralla Jan, Nedeltchev Krassen, Mattle Heinrich Paul, Arnold Marcel
Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysis.
Jung S, Mono M, Fischer U, Galimanis A, Findling O, De Marchis G, Weck A, Nedeltchev K, Colucci G, Mordasini P, Brekenfeld C, El-Koussy M, Gralla J, Schroth G, Mattle H, Arnold M. Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysis. Stroke 2011; 42:1946-51.
May 5, 2011Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysis.
May 5, 2011Stroke 2011; 42:1946-51
Jung Simon, Mono Marie-Luise, Fischer Urs, Galimanis Aekaterini, Findling Oliver, De Marchis Gian Marco, Weck Anja, Nedeltchev Krassen, Colucci Giuseppe, Mordasini Pasquale, Brekenfeld Caspar, El-Koussy Marwan, Gralla Jan, Schroth Gerhard, Mattle Heinrich Paul, Arnold Marcel